JD Supra: Mergers
JUNE 25, 2025
The case arose from Alexion Pharmaceuticals, Inc.’s s 2018 acquisition of Syntimmune, Inc. A recent Delaware Chancery Court opinion offers a significant example of how courts may apply complex probability analysis to determine the amount of damages in an earnout dispute.
MergersCorp M&A International
NOVEMBER 16, 2024
His presidency brought with it a unique set of policies and attitudes that would directly influence the realm of mergers and acquisitions (M&A). These regulatory rollbacks naturally benefitted companies considering mergers and acquisitions. Foreign companies sought to acquire U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cooley M&A
JANUARY 22, 2025
While global M&A deal value across sectors remained relatively flat overall , pharmaceuticals and life sciences M&A in 2024 dipped relative to the prior year. Indeed, the largest US biotech exit in 2024 was Vertex Pharmaceuticals $4.9 Total deal value is where the market really shed its weight down a remarkable 33.7%
CNBC: Investing
JUNE 12, 2025
Last month, Goldman Sachs lifted its price target on the pharmaceutical giant to $176 from $172, placing Johnson & Johnson on its conviction list. Last month, the Gatorade maker completed its acquisition of probiotic soda brand Poppi for $1.95 Shares are up more than 7% in 2025, and the stock pays a dividend yield of about 3.4%.
Sun Acquisitions
JUNE 17, 2025
Healthcare Manufacturing Stands Out Two subsectors— Pharmaceutical Manufacturing and Medical Devices & Supplies —are drawing particularly deep interest. PE firms investing domestically —far surpassing the number of outbound (89) and inbound (27) transactions, a sign of confidence in American manufacturing resilience.
Private Equity Info
JUNE 9, 2025
Two sectors stand out for their role in advancing healthcare: Pharmaceutical and Medicine Manufacturing This sector has been a magnet for PE interest due to its resilience, regulatory clarity, and innovation pipeline. That’s more than six times the number of outbound U.S. All rights reserved.
JD Supra: Mergers
JUNE 16, 2025
Great Point Partners (GPP) has announced the acquisition of a majority stake in Eutecma. Eutecma, founded in 2008 and based in Germany, is a developer of temperature-controlled packaging solutions for pharmaceutical cold chain shipments. By: McGuireWoods LLP
Expert insights. Personalized for you.
Let's personalize your content